Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

13.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.9K
Multi-pass Transmembrane Proteins and β-barrels01:09

Multi-pass Transmembrane Proteins and β-barrels

5.6K
In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
5.6K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

6.0K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.0K
Structure of Cadherins01:25

Structure of Cadherins

3.6K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
3.6K
Mechanisms of Membrane Domain Formation00:59

Mechanisms of Membrane Domain Formation

3.3K
Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with...
3.3K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

11.6K
Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
11.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with high-volume metastatic hormone-sensitive prostate cancer: a retrospective multicenter cohort study.

Translational andrology and urology·2026
Same author

Calcitriol Suppresses Platelet Activation and Thrombosis, Mitigating Cardiovascular Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease.

JACC. Basic to translational science·2026
Same author

Structural insights into the binding of CX-5461 and MTR-106 to G-quadruplex DNA.

Nucleic acids research·2026
Same author

Directed Construction of Hierarchical Porous Carbon With Ultrahigh Surface Area for High-Density Methane Storage at Room Temperature.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Automatic pain assessment from facial action units in ICU patients via various machine learning models.

Scientific reports·2026
Same author

Metabolic Crosstalk Between Host and Tumor as a Circuit of Resilience in Cancer Therapy.

Cells·2026

Related Experiment Video

Updated: Sep 27, 2025

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
06:45

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay

Published on: May 26, 2011

15.3K

Structural characterization of a dimerization interface in the CD28 transmembrane domain.

Hongyi Wu1, Ruiyu Cao1, Maorong Wen2

  • 1State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Structure (London, England : 1993)
|April 9, 2022
PubMed
Summary

The CD28 transmembrane helix (TMH) unexpectedly forms tetramers, not dimers. Specific mutations disrupt TMH assembly, impacting CD28 function in immune responses.

Keywords:
CD28 transmembrane domainNMR structuredimer interfacefunctional mutagenesis

More Related Videos

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
12:05

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies

Published on: March 6, 2013

14.3K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.5K

Related Experiment Videos

Last Updated: Sep 27, 2025

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
06:45

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay

Published on: May 26, 2011

15.3K
Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
12:05

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies

Published on: March 6, 2013

14.3K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.5K

Area of Science:

  • Immunology
  • Structural Biology
  • Biophysics

Background:

  • CD28 is vital for T cell activation and immune response regulation.
  • The CD28 transmembrane helix (TMH) is implicated in receptor assembly and activity.
  • Structural data on the CD28-TMH is currently lacking.

Purpose of the Study:

  • To structurally characterize the dimeric helix-helix packing of CD28-TMH.
  • To investigate the role of specific motifs in CD28-TMH assembly and function.

Main Methods:

  • Nuclear magnetic resonance (NMR) technology was employed.
  • Structural determination of wild-type and mutant CD28-TMH in lipid bicelles.
  • Functional assays in cells to assess CD28 enhancement.

Main Results:

  • Wild-type CD28-TMH forms stable tetramers, not dimers, in lipid bicelles.
  • A conserved GxxxA motif at the dimerization interface is crucial for TMH assembly.
  • Mutations in the GxxxA motif disrupt TMH assembly and reduce CD28-mediated enhancement.
  • A proposed YxxxxT motif did not affect dimerization but influenced CD28 activity.

Conclusions:

  • The CD28-TMH exhibits tetrameric assembly, challenging previous assumptions.
  • The GxxxA motif plays a key role in CD28-TMH oligomerization and function.
  • CD28 transmembrane domain regulation of signaling is complex and multifaceted.